[2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide

C91H106N16O4Pt3 — CID 158713985

IUPAC[2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide
SMILESCC(=O)C=C(C)O.CC(=O)C=C(C)O.CC(C)(C)c1cc(-c2nc(C(C)(C)C[N-]Cc3ccccn3)cc3ccccc23)[n-]n1.CC(C)(C[N-]Cc1ccccn1)c1cccc(-c2[n-]nc3c2C2CCC3(C)C2(C)C)n1.CC12CCC(c3c1n[n-]c3-c1cccc(N(C[N-]Cc3ccccn3)c3ccccc3)n1)C2(C)C.[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C29H30N6.C26H31N5.C26H29N5.2C5H8O2.3Pt/c1-28(2)22-15-16-29(28,3)27-25(22)26(33-34-27)23-13-9-14-24(32-23)35(21-11-5-4-6-12-21)19-30-18-20-10-7-8-17-31-20;1-24(2,16-27-15-17-9-6-7-14-28-17)20-11-8-10-19(29-20)22-21-18-12-13-26(5,25(18,3)4)23(21)31-30-22;1-25(2,3)22-15-21(30-31-22)24-20-12-7-6-10-18(20)14-23(29-24)26(4,5)17-27-16-19-11-8-9-13-28-19;2*1-4(6)3-5(2)7;;;/h4-14,17,22H,15-16,18-19H2,1-3H3;6-11,14,18H,12-13,15-16H2,1-5H3;6-15H,16-17H2,1-5H3;2*3,6H,1-2H3;;;/q3*-2;;;3*+2
InChIKeyCHTXAUPZBPUATJ-UHFFFAOYSA-N
MW2073.19 g/mol
LogP19.73
Rot. Bonds21

About [2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide

[2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide (PubChem CID 158713985) has the molecular formula C91H106N16O4Pt3 and a molecular weight of 2073.19 g/mol. Its IUPAC name is [2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide.

Molecular Properties

Compound Name[2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide
PubChem CID158713985
Molecular FormulaC91H106N16O4Pt3
Molecular Weight2073.19 g/mol
Exact Mass2071.75
IUPAC Name[2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide
SMILESCC(=O)C=C(C)O.CC(=O)C=C(C)O.CC(C)(C)c1cc(-c2nc(C(C)(C)C[N-]Cc3ccccn3)cc3ccccc23)[n-]n1.CC(C)(C[N-]Cc1ccccn1)c1cccc(-c2[n-]nc3c2C2CCC3(C)C2(C)C)n1.CC12CCC(c3c1n[n-]c3-c1cccc(N(C[N-]Cc3ccccn3)c3ccccc3)n1)C2(C)C.[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/C29H30N6.C26H31N5.C26H29N5.2C5H8O2.3Pt/c1-28(2)22-15-16-29(28,3)27-25(22)26(33-34-27)23-13-9-14-24(32-23)35(21-11-5-4-6-12-21)19-30-18-20-10-7-8-17-31-20;1-24(2,16-27-15-17-9-6-7-14-28-17)20-11-8-10-19(29-20)22-21-18-12-13-26(5,25(18,3)4)23(21)31-30-22;1-25(2,3)22-15-21(30-31-22)24-20-12-7-6-10-18(20)14-23(29-24)26(4,5)17-27-16-19-11-8-9-13-28-19;2*1-4(6)3-5(2)7;;;/h4-14,17,22H,15-16,18-19H2,1-3H3;6-11,14,18H,12-13,15-16H2,1-5H3;6-15H,16-17H2,1-5H3;2*3,6H,1-2H3;;;/q3*-2;;;3*+2
InChIKeyCHTXAUPZBPUATJ-UHFFFAOYSA-N
XLogP19.73
TPSA278.45 Ų
H-Bond Donors2
H-Bond Acceptors14
Rotatable Bonds21
Heavy Atoms114
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002073.19
LogP ≤ 519.73
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze [2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide?
The IUPAC name of [2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide (CID 158713985) is [2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide.
What is the SMILES notation for [2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide?
The canonical SMILES for [2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide is CC(=O)C=C(C)O.CC(=O)C=C(C)O.CC(C)(C)c1cc(-c2nc(C(C)(C)C[N-]Cc3ccccn3)cc3ccccc23)[n-]n1.CC(C)(C[N-]Cc1ccccn1)c1cccc(-c2[n-]nc3c2C2CCC3(C)C2(C)C)n1.CC12CCC(c3c1n[n-]c3-c1cccc(N(C[N-]Cc3ccccn3)c3ccccc3)n1)C2(C)C.[Pt+2].[Pt+2].[Pt+2].
What is the InChIKey of [2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide?
The InChIKey is CHTXAUPZBPUATJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H30N6.C26H31N5.C26H29N5.2C5H8O2.3Pt/c1-28(2)22-15-16-29(28,3)27-25(22)26(33-34-27)23-13-9-14-24(32-23)35(21-11-5-4-6-12-21)19-30-18-20-10-7-8-17-31-20;1-24(2,16-27-15-17-9-6-7-14-28-17)20-11-8-10-19(29-20)22-21-18-12-13-26(5,25(18,3)4)23(21)31-30-22;1-25(2,3)22-15-21(30-31-22)24-20-12-7-6-10-18(20)14-23(29-24)26(4,5)17-27-16-19-11-8-9-13-28-19;2*1-4(6)3-5(2)7;;;/h4-14,17,22H,15-16,18-19H2,1-3H3;6-11,14,18H,12-13,15-16H2,1-5H3;6-15H,16-17H2,1-5H3;2*3,6H,1-2H3;;;/q3*-2;;;3*+2.
What are the key properties of [2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide?
[2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide has a molecular weight of 2073.19 g/mol, XLogP of 19.73, 21 rotatable bonds, 2 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[1-(3-tert-butylpyrazol-1-id-5-yl)isoquinolin-3-yl]-2-methylpropyl]-(pyridin-2-ylmethyl)azanide;bis(4-hydroxypent-3-en-2-one);[2-methyl-2-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]propyl]-(pyridin-2-ylmethyl)azanide;tris(platinum(2+));pyridin-2-ylmethyl-[(N-[6-(1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-dien-5-yl)-2-pyridinyl]anilino)methyl]azanide is sourced from PubChem (CID 158713985), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).